Caprock Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$810K Buy
8,771
+585
+7% +$58.7K 0.02% 602
2025
Q4
$836K Buy
8,186
+301
+4% +$26.9K 0.02% 650
2025
Q3
$532K Buy
+7,885
New +$429K 0.01% 786
2025
Q1
$385K Buy
+9,041
New +$390K 0.01% 808

Other funds holding GH

Caprock Group's GH Position: Q1 2026 in Review

Caprock Group increased its Guardant Health (GH) stake by 7.1% in Q1 2026, buying an estimated $58.7K and bringing the position to 8,771 shares worth $810K. The position accounts for 0.02% of the portfolio, ranked #602.

Caprock Group first reported a position in GH in Q1 2025 and has held it in 4 quarters since. The position peaked at $836K in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Caprock Group held 8,771 shares of Guardant Health worth $810K as of Q1 2026.
  • Caprock Group bought 585 Guardant Health shares in Q1 2026, an estimated $58.7K.
  • Guardant Health made up 0.02% of Caprock Group's portfolio in Q1 2026, its #602 holding.
  • Caprock Group first reported a position in Guardant Health in Q1 2025 and has held it in 4 quarters since.
  • Caprock Group's Guardant Health position peaked at $836K in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.